US Archives - Page 167 of 188 - European Medical Journal

CDC Warns of Oropouche Virus Sexual Transmission Risk

Ninety cases of imported Oropouche virus have been reported across five states, primarily in Florida, according to the U.S. Centers for Disease Control and Prevention (CDC).

Avian Flu and Mpox: Emerging Pandemic Risks

The Global Preparedness Monitoring Board (GPMB) has released its latest annual report, spotlighting avian flu and mpox as significant emerging threats with pandemic potential.

Lupus in Pregnancy Linked to Placental Damage

Systemic lupus erythematosus impacts placental health, particularly in pregnancies resulting in small for gestational age infants.

CDC Warns of Rising Pneumonia and RSV in Children

A reported rise in respiratory infections has been issued by the U.S. CDC, particularly Mycoplasma pneumonia and RSV.

Ketamine Treatment for Bipolar Shows Full Remission

Ketamine treatment for bipolar depression may offer new hope, as new research has revealed its potential as a treatment option in real-world settings to significantly reduce symptoms in patients resistant to traditional therapies.

Can Diet Quality Slow Prostate Cancer?

Diet quality could play a role in the progression of prostate cancer for men undergoing active surveillance.

Advanced Lung Cancer Wearable Receives FDA Approval

The U.S. FDA has approved a wearable device for treating metastatic non-small cell lung cancer in adults. Used with PD-1/PD-L1 inhibitors or docetaxel, it showed a median survival of 13.2 months.

Race and Socioeconomic Factors Reveal Low Vaccine Rates: IDWeek 2024

Vaccination rates in the U.S. continue to lag, and new research presented at IDWeek 2024 in Los Angeles, California, underscored the role social vulnerabilities play in access to preventive healthcare.

24-Hour Therapy for Parkinson’s: The First Of Its Kind

The U.S. FDA has approved a 24-hour continuous subcutaneous infusion for adults with advanced Parkinson’s disease. This therapy is the first of its kind.

Pre-Exposure Prophylaxis Uptake Across US: IDWeek 2024

Use of pre-exposure prophylaxis (PrEP), an HIV-1 prevention strategy, across diverse demographic groups is not consistent, despite importance of the tool.